Can-Fite BioPharma Ltd. Operating Expenses
Can-Fite BioPharma Ltd. (CANF) reported Operating Expenses of $10.36 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-03-26
| Period end | Operating Expenses 12 month |
|---|---|
| 2025-12-31 | $10.36M 20-F · filed 2026-03-26 |
| 2024-12-31 | $8.80M 20-F · filed 2026-03-26 |
| 2023-12-31 | $8.94M 20-F · filed 2026-03-26 |
| 2022-12-31 | $10.91M 20-F · filed 2025-04-14 |